<DOC>
	<DOC>NCT00092495</DOC>
	<brief_summary>The primary purpose of the study is to determine if an investigational vaccine Gardasil (V501) with 4 components will provide an immune response and will be well tolerated in pre-adolescents and adolescents.</brief_summary>
	<brief_title>Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adolescents and preadolescents with no prior sexual history Healthy women who have an intact uterus with lifetime history of 04 sexual partners Prior Human Papillomavirus (HPV) vaccination Prior abnormal Paps Prior history of genital warts</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>23 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>